cell and gene therapy

News

European union flag against parliament in Brussels, Belgium

Gene therapy trials held back by fragmented EU rules

Biotech and pharma organisations are calling for EU countries to harmonise regulations, or otherwise face falling behind in cutting-edge gene and cell therapy trials.

Views & Analysis

UK pharma stays ambitious despite Brexit, looks to new era i...

The UK can be a leader in cell and gene therapy, but Brexit is a once-in-a-generation challenge

News

Novartis and FDA hail 'historic' Kymriah, first ever approve...

In the end, the FDA took little more than six weeks to give final approval to Kymriah, the first ever CAR-T treatment.

News

Novartis close to first-ever CAR-T approval after unanimous ...

Panel unanimously back CTL019

News

Novartis CAR-T safety in FDA spotlight

FDA advisers are set to make recommendations on Novartis’ groundbreaking CAR-T therapy CTL019 tomorrow – and are set to focus on safety concerns in the decisive meeting.

News